GB2135647A
(en)
*
|
1983-02-15 |
1984-09-05 |
Squibb & Sons Inc |
Method of preparing liposomes and products produced thereby
|
JPS6058915A
(ja)
*
|
1983-09-12 |
1985-04-05 |
Fujisawa Pharmaceut Co Ltd |
薬物含有脂質小胞体製剤
|
JPS60155109A
(ja)
*
|
1984-01-23 |
1985-08-15 |
Terumo Corp |
リポソ−ム製剤
|
US4744989A
(en)
*
|
1984-02-08 |
1988-05-17 |
E. R. Squibb & Sons, Inc. |
Method of preparing liposomes and products produced thereby
|
GB8613811D0
(en)
*
|
1986-06-06 |
1986-07-09 |
Phares Pharm Res Nv |
Composition & method
|
US5141674A
(en)
*
|
1984-03-08 |
1992-08-25 |
Phares Pharmaceutical Research N.V. |
Methods of preparing pro-liposome dispersions and aerosols
|
US5231112A
(en)
|
1984-04-12 |
1993-07-27 |
The Liposome Company, Inc. |
Compositions containing tris salt of cholesterol hemisuccinate and antifungal
|
US4891208A
(en)
*
|
1985-04-10 |
1990-01-02 |
The Liposome Company, Inc. |
Steroidal liposomes
|
GB8423436D0
(en)
*
|
1984-09-17 |
1984-10-24 |
Riker Laboratories Inc |
Preparation of liposomes
|
US4830858A
(en)
*
|
1985-02-11 |
1989-05-16 |
E. R. Squibb & Sons, Inc. |
Spray-drying method for preparing liposomes and products produced thereby
|
JPH0676308B2
(ja)
*
|
1985-06-18 |
1994-09-28 |
ポーラ化成工業株式会社 |
皮膚外用剤
|
US4683092A
(en)
*
|
1985-07-03 |
1987-07-28 |
Damon Biotech, Inc. |
Capsule loading technique
|
US5230899A
(en)
*
|
1985-08-07 |
1993-07-27 |
Smithkline Beecham Corporation |
Methods and compositions for making liposomes
|
IL79114A
(en)
*
|
1985-08-07 |
1990-09-17 |
Allergan Pharma |
Method and composition for making liposomes
|
GB8522964D0
(en)
*
|
1985-09-17 |
1985-10-23 |
Biocompatibles Ltd |
Aerosol
|
ATE71540T1
(de)
*
|
1985-10-21 |
1992-02-15 |
Liposome Co Inc |
In situ-herstellung und verabreichung von liposomen.
|
FR2591105B1
(fr)
|
1985-12-11 |
1989-03-24 |
Moet Hennessy Rech |
Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
|
JPS62152531A
(ja)
*
|
1985-12-26 |
1987-07-07 |
Dai Ichi Seiyaku Co Ltd |
リポソ−ムの製造法
|
US5023108A
(en)
*
|
1986-01-13 |
1991-06-11 |
Research Corporation |
Aqueous dispersions of waxes and lipids for pharmaceutical coating
|
EP0321457A1
(de)
*
|
1986-01-13 |
1989-06-28 |
Research Corporation |
Wässrige dispersionen von wachsen und lipiden für arzneimittelbeschichtungen
|
US4737323A
(en)
*
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
FR2597345B1
(fr)
*
|
1986-04-22 |
1990-08-03 |
Oreal |
Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques.
|
US4781871A
(en)
*
|
1986-09-18 |
1988-11-01 |
Liposome Technology, Inc. |
High-concentration liposome processing method
|
AU598601B2
(en)
*
|
1986-09-18 |
1990-06-28 |
Liposome Technology, Inc. |
High-concentration liposome processing method
|
CA1308025C
(en)
*
|
1986-11-28 |
1992-09-29 |
Paul A. Tremblay |
Phospholipid composition
|
JPS63182029A
(ja)
*
|
1987-01-22 |
1988-07-27 |
Agency Of Ind Science & Technol |
リポソ−ム
|
ATE115403T1
(de)
*
|
1987-01-27 |
1994-12-15 |
Vestar Inc |
Aus phospholipiden bestehende darreichungsform für wasserunlösliche wirksubstanzen.
|
JP2677647B2
(ja)
*
|
1987-02-24 |
1997-11-17 |
ネクスター・フアーマシユーテイカルズ・インコーポレイテツド |
リポリーム製剤の脱水方法
|
US5089181A
(en)
*
|
1987-02-24 |
1992-02-18 |
Vestar, Inc. |
Method of dehydrating vesicle preparations for long term storage
|
US6406713B1
(en)
|
1987-03-05 |
2002-06-18 |
The Liposome Company, Inc. |
Methods of preparing low-toxicity drug-lipid complexes
|
US5616334A
(en)
*
|
1987-03-05 |
1997-04-01 |
The Liposome Company, Inc. |
Low toxicity drug-lipid systems
|
NZ223660A
(en)
*
|
1987-03-05 |
1990-11-27 |
Liposome Co Inc |
Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity
|
IT1223290B
(it)
*
|
1987-07-27 |
1990-09-19 |
Indena Spa |
Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
|
US4963362A
(en)
*
|
1987-08-07 |
1990-10-16 |
Regents Of The University Of Minnesota |
Freeze-dried liposome mixture containing cyclosporin
|
FR2619505B1
(fr)
*
|
1987-08-20 |
1990-08-31 |
Dior Christian Parfums |
Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
|
US4950432A
(en)
*
|
1987-10-16 |
1990-08-21 |
Board Of Regents, The University Of Texas System |
Polyene microlide pre-liposomal powders
|
US5057497A
(en)
*
|
1987-11-10 |
1991-10-15 |
Calam & Associates, Inc. |
Oral method for the maintenance of healthy gingival tissues using TRF
|
US5290562A
(en)
*
|
1987-11-27 |
1994-03-01 |
L V M H Recherche |
Compositions and methods employing liposomes including tyrosine or a tyrosine derivative
|
FR2623716B1
(fr)
*
|
1987-11-27 |
1991-04-05 |
Lvmh Rech |
Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la tyrosine ou un derive de tyrosine et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite pigmentante, l'incorporant
|
US5160669A
(en)
*
|
1988-03-03 |
1992-11-03 |
Micro Vesicular Systems, Inc. |
Method of making oil filled paucilamellar lipid vesicles
|
CA1340241C
(en)
*
|
1988-06-08 |
1998-12-15 |
Fountain Pharmaceuticals, Inc. |
Method for marking solvent dilution microcarriers
|
US5269979A
(en)
*
|
1988-06-08 |
1993-12-14 |
Fountain Pharmaceuticals, Inc. |
Method for making solvent dilution microcarriers
|
US5133965A
(en)
*
|
1988-06-08 |
1992-07-28 |
Fountain Pharmaceuticals, Inc. |
Dressing material having adsorbed thereon a solvent dilution microcarrier precursor solution
|
FR2633516B1
(fr)
*
|
1988-06-30 |
1991-03-29 |
Clarins |
Composition cosmetique pour le traitement des peaux sensibles deshydratees
|
US5096629A
(en)
*
|
1988-08-29 |
1992-03-17 |
501 Nippon Fine Chemical Co., Ltd. |
Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes
|
FR2637182B1
(fr)
*
|
1988-10-03 |
1992-11-06 |
Lvmh Rech |
Compositions a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un ecdysteroide, de preference l'ecdysterone, ou l'un de ses derives; et compositions cosmetiques, pharmaceutiques, notamment dermatologiques, de sericulture ou phytosanitaires l'incorporant
|
US5139803A
(en)
*
|
1989-02-09 |
1992-08-18 |
Nabisco, Inc. |
Method and liposome composition for the stabilization of oxidizable substances
|
US5015483A
(en)
*
|
1989-02-09 |
1991-05-14 |
Nabisco Brands, Inc. |
Liposome composition for the stabilization of oxidizable substances
|
US5549910A
(en)
*
|
1989-03-31 |
1996-08-27 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
US5277914A
(en)
*
|
1989-03-31 |
1994-01-11 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
US5077057A
(en)
*
|
1989-04-05 |
1991-12-31 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
FR2648462B1
(fr)
*
|
1989-06-15 |
1994-01-28 |
Oreal |
Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
|
US5174988A
(en)
*
|
1989-07-27 |
1992-12-29 |
Scientific Development & Research, Inc. |
Phospholipid delivery system
|
DE69103487T2
(de)
*
|
1990-07-11 |
1995-02-16 |
Quest Int |
Parfümierte strukturierte Emulsionen in Körperpflegemitteln.
|
US5246918A
(en)
*
|
1990-07-11 |
1993-09-21 |
Unilever Patent Holdings B.V. |
Process for preparing perfumed personal products
|
DE69101474T2
(de)
*
|
1990-07-11 |
1994-07-21 |
Quest Int |
Stabilisiertes Emulsionssystem.
|
FR2673840A1
(fr)
*
|
1991-03-14 |
1992-09-18 |
Lvmh Rech |
Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant de l'oxyacanthine, en particulier destinee a stimuler la pousse des cheveux ou a retarder leur chute.
|
US5498420A
(en)
*
|
1991-04-12 |
1996-03-12 |
Merz & Co. Gmbh & Co. |
Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
|
FR2681781A1
(fr)
*
|
1991-09-30 |
1993-04-02 |
Oreal |
Composition cosmetique anhydre de maquillage comprenant une phase grasse et procede de traitement cosmetique utilisant cette composition.
|
FR2735658B1
(fr)
*
|
1995-06-21 |
1997-09-12 |
Capsulis |
Encapsulation de composes a usage alimentaire par des tensioactifs
|
CA2087691A1
(en)
*
|
1992-01-23 |
1993-07-24 |
Peter Critchley |
Cosmetic compositon
|
GB9208339D0
(en)
*
|
1992-04-15 |
1992-06-03 |
Unilever Plc |
Treatment composition
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
FR2695035A1
(fr)
*
|
1992-08-25 |
1994-03-04 |
Lvmh Rech Gie |
Utilisation d'un ecdystéroïde pour la préparation de compositions cosmétiques ou dermatologiques destinées notamment à renforcer la fonction protectrice de la peau, et compositions ainsi obtenues.
|
US5958449A
(en)
*
|
1992-12-02 |
1999-09-28 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for bacterial infections
|
AU3244393A
(en)
*
|
1992-12-02 |
1994-06-22 |
Vestar, Inc. |
Antibiotic formulation and process
|
FR2699081B1
(fr)
*
|
1992-12-11 |
1995-04-07 |
Lvmh Rech |
Utilisation d'un extrait de Simaba pour l'atténuation des taches pigmentaires cutanées ou pour renforcer la fonction protectrice de la peau, ou pour la préparation d'un milieu de culture de cellules de peau, et composition ainsi obtenue.
|
FR2699080B1
(fr)
*
|
1992-12-11 |
1995-04-07 |
Lvmh Rech |
Utilisation d'un extrait de Simarouba pour l'atténuation des taches pigmentaires cutanées ou pour renforcer la fonction protectrice de la peau, ou pour la préparation d'un milieu de culture de cellules de peau, et composition ainsi obtenue.
|
US5759571A
(en)
*
|
1993-05-11 |
1998-06-02 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for drug resistant infections
|
US5554382A
(en)
*
|
1993-05-28 |
1996-09-10 |
Aphios Corporation |
Methods and apparatus for making liposomes
|
AU689786B2
(en)
*
|
1993-06-30 |
1998-04-09 |
Genentech Inc. |
Method for preparing liposomes
|
DE4430592A1
(de)
*
|
1994-08-20 |
1996-02-22 |
Max Delbrueck Centrum |
Liposomale Zubereitung, ihre Herstellung und ihre Verwendung
|
US5702722A
(en)
*
|
1994-09-30 |
1997-12-30 |
Bracco Research S.A. |
Liposomes with enhanced entrapment capacity, method and use
|
CH689139A5
(de)
*
|
1995-04-03 |
1998-10-30 |
Cerbios Pharma Sa |
Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
|
US20030032610A1
(en)
|
1996-06-03 |
2003-02-13 |
Gilchrest Barbara A. |
Method to inhibit cell growth using oligonucleotides
|
US6147056A
(en)
*
|
1995-06-06 |
2000-11-14 |
Trustees Of Boston University |
Use of locally applied DNA fragments
|
US7094766B1
(en)
|
1995-06-06 |
2006-08-22 |
Trustees Of Boston University |
Use of locally applied DNA fragments
|
US5891467A
(en)
|
1997-01-31 |
1999-04-06 |
Depotech Corporation |
Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
|
IN187860B
(de)
*
|
1997-08-27 |
2002-07-06 |
Revlon Consumer Prod Corp |
|
US6287590B1
(en)
*
|
1997-10-02 |
2001-09-11 |
Esperion Therapeutics, Inc. |
Peptide/lipid complex formation by co-lyophilization
|
US5932562A
(en)
*
|
1998-05-26 |
1999-08-03 |
Washington University |
Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same
|
AU6333499A
(en)
*
|
1998-10-14 |
2000-05-01 |
Cognis Deutschland Gmbh |
Use of nanoscale sterols and sterol esters
|
FR2787322B1
(fr)
*
|
1998-12-18 |
2002-10-18 |
Galderma Res & Dev |
Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
|
US6080211A
(en)
*
|
1999-02-19 |
2000-06-27 |
Igen, Inc. |
Lipid vesicle-based fuel additives and liquid energy sources containing same
|
CA2376818A1
(en)
*
|
1999-06-25 |
2001-01-04 |
Cognis Deutschland Gmbh & Co. Kg |
Use of nanoscale sterols and sterol esters
|
AU2001251115A1
(en)
*
|
2000-03-31 |
2001-10-15 |
Trustees Of Boston University |
Use of locally applied dna fragments
|
US6759058B1
(en)
*
|
2001-04-25 |
2004-07-06 |
Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences |
Enteric-coated proliposomal formulations for poorly water soluble drugs
|
US8658202B2
(en)
|
2001-04-25 |
2014-02-25 |
Western University Of Health Sciences |
Coated drug delivery formulations
|
BRPI0105509B8
(pt)
|
2001-11-05 |
2021-05-25 |
Univ Minas Gerais |
formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
|
US20050129722A1
(en)
*
|
2002-03-13 |
2005-06-16 |
Collagenex Pharmaceuticals, Inc. |
Water-based delivery systems
|
US20040009213A1
(en)
*
|
2002-03-13 |
2004-01-15 |
Thomas Skold |
Water-based delivery systems
|
US20060093661A1
(en)
*
|
2002-05-07 |
2006-05-04 |
Kapac, Llc |
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
|
US20030212046A1
(en)
*
|
2002-05-07 |
2003-11-13 |
Kapac, Llc |
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
|
JP4773720B2
(ja)
*
|
2002-06-12 |
2011-09-14 |
ザ・コカ−コーラ・カンパニー |
植物ステロール含有飲料
|
US7306819B2
(en)
*
|
2002-06-12 |
2007-12-11 |
The Coca-Cola Company |
Beverages containing plant sterols
|
US20060269924A1
(en)
*
|
2003-04-11 |
2006-11-30 |
Trustees Of Boston University |
Modulation of telomere-initiated cell signaling
|
US20050153948A1
(en)
*
|
2003-11-20 |
2005-07-14 |
Zomanex, Llc |
Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone
|
AU2005245932A1
(en)
|
2004-05-19 |
2005-12-01 |
Trustees Of Boston University |
Modulation of WRN-mediated telomere-initiated cell signaling
|
EP1835922B1
(de)
*
|
2004-12-22 |
2009-05-20 |
Merck Serono SA |
Kombinationstherapie gegen multiple sklerose
|
ES2275443B1
(es)
|
2005-11-30 |
2008-06-01 |
Italfarmaco, S.A. |
Procedimiento de preparacion de liposomas.
|
JP2007261984A
(ja)
*
|
2006-03-28 |
2007-10-11 |
Konica Minolta Medical & Graphic Inc |
脂肪酸エステルを有するリポソ−ムおよびその製剤
|
US8007790B2
(en)
|
2006-04-03 |
2011-08-30 |
Stowers Institute For Medical Research |
Methods for treating polycystic kidney disease (PKD) or other cyst forming diseases
|
CA2663580C
(en)
|
2006-09-18 |
2015-03-17 |
Compugen Ltd |
Bioactive peptides and method of using same
|
US20080124387A1
(en)
|
2006-11-27 |
2008-05-29 |
Kapac, Llc |
Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients
|
GB0623838D0
(en)
*
|
2006-11-29 |
2007-01-10 |
Malvern Cosmeceutics Ltd |
Novel compositions
|
US20080207711A1
(en)
*
|
2007-02-28 |
2008-08-28 |
Rong Li |
Method for treating an ID2-related disorder
|
US8492329B2
(en)
|
2007-07-12 |
2013-07-23 |
Compugen Ltd. |
Bioactive peptides and methods of using same
|
US20090088393A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Zomanex, Llc |
Methods and formulations for converting intravenous and injectable drugs into oral dosage forms
|
MX2010004195A
(es)
|
2007-10-16 |
2010-06-02 |
Repros Therapeutics Inc |
Trans-clomifeno para el sindrome metabolico.
|
US8101606B2
(en)
*
|
2007-11-12 |
2012-01-24 |
Washington University |
Neurofibromin pathway modulators
|
EP3561494B1
(de)
|
2007-12-06 |
2022-03-02 |
Genalyte, Inc. |
VERFAHREN ZUM IDENTIFIZIEREN EINER SEQUENZ VON NUKLEOTIDEN IN EINER UNBEKANNTEN SPEZIES VON NUKLEINSÄURE
UND VORRICHTUNG ZUR DURCHFÜHRUNG DES VERFAHRENS
|
TWI539953B
(zh)
|
2008-04-28 |
2016-07-01 |
瑞波若斯治療學公司 |
用於治療乳癌之組成物和方法
|
TWI477276B
(zh)
|
2008-04-28 |
2015-03-21 |
Repros Therapeutics Inc |
抗黃體素給藥方案
|
ES2939310T3
(es)
|
2008-10-27 |
2023-04-20 |
Genalyte Inc |
Biosensores basados en sondeo y detección ópticos
|
US10143652B2
(en)
|
2009-09-23 |
2018-12-04 |
Curirx Inc. |
Methods for the preparation of liposomes
|
EP2480208A1
(de)
|
2009-09-23 |
2012-08-01 |
Indu Javeri |
Verfahren zur herstellung von liposomen
|
CN107260746A
(zh)
|
2010-03-22 |
2017-10-20 |
利普生物药剂公司 |
用于抗孕酮的非毒性递送的组合物和方法
|
EP2813220A3
(de)
|
2010-04-09 |
2015-06-17 |
Pacira Pharmaceuticals, Inc. |
Verfahren zur Formulierung synthetischer Membranvesikel mit hohem Durchmesser
|
WO2012061778A2
(en)
|
2010-11-05 |
2012-05-10 |
Genalyte, Inc. |
Optical analyte detection systems and methods of use
|
UA113283C2
(xx)
|
2010-12-23 |
2017-01-10 |
|
19-норстероїди і їх застосування для лікування прогестеронзалежних станів
|
EP2907504B1
(de)
|
2011-02-08 |
2017-06-28 |
Halozyme, Inc. |
Zusammensetzung und Lipidformulierung eines Hyaluronan-abbauenden Enzyms und seiner Verwendung zur Behandlung von benigner Prostatahyperplasie
|
US20130261010A1
(en)
|
2012-03-12 |
2013-10-03 |
The Board Of Trustees Of The University Of Illinois |
Optical analyte detection systems with magnetic enhancement and methods of use
|
EP2854763B1
(de)
|
2012-05-31 |
2018-09-26 |
Repros Therapeutics Inc. |
Formulierungen zur vaginalen abgabe von antiprogestinen
|
WO2014070517A1
(en)
|
2012-11-02 |
2014-05-08 |
Repros Therapeutics Inc. |
Methods and compositions for treating progesterone-dependent conditions
|
ES2727137T3
(es)
|
2014-08-28 |
2019-10-14 |
Halozyme Inc |
Terapia combinada con una enzima de degradación de hialuronano y un inhibidor de puntos de control inmunitario
|
US10406088B2
(en)
|
2015-01-20 |
2019-09-10 |
TetraDerm Group LLC |
Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration
|
CN107750156B
(zh)
|
2015-05-04 |
2020-08-21 |
沃桑缇斯股份公司 |
用于制备跨膜pH梯度囊泡的方法
|
ES2781459T3
(es)
|
2015-07-29 |
2020-09-02 |
Ifom Fondazione St Firc Di Oncologia Molecolare |
Oligonucleótidos terapéuticos
|
EP3124609A1
(de)
|
2015-07-29 |
2017-02-01 |
IFOM Fondazione Istituto Firc di Oncologia Molecolare |
Therapeutische oligonukleotide
|
WO2017027622A1
(en)
|
2015-08-11 |
2017-02-16 |
Scintillon Institute For Biomedical And Bioenergy Research |
Optical analyses of particles and vesicles
|
ITUA20161994A1
(it)
|
2016-03-24 |
2017-09-24 |
Azienda Ospedaliera Univ Senese |
Uso degli inibitori ddx3 come agenti anti-iperproliferativi
|
WO2020023340A1
(en)
|
2018-07-23 |
2020-01-30 |
Signalrx Pharmaceuticals, Inc. |
Single molecule compounds providing multi-target inhibition of btk and other proteins and methods of use thereof
|
MX2021002882A
(es)
|
2018-09-12 |
2021-07-16 |
Broad Inst Inc |
Focalizacion de egln1 en el cancer.
|
EP4050002A1
(de)
|
2021-02-26 |
2022-08-31 |
First Health Pharmaceuticals B.V. |
Antiproliferative wirkstoffe
|